Global Autism Spectrum Disorder Industry Growth and Trends Forecast to 2031
Description
Summary
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child’s behavior and development to make a diagnosis. Our report studies the market from 2014-2025, examining programs and medications used to the patient with autism.
Symptoms and Signs
Autism spectrum disorders may manifest during the first year of life but, depending on severity of symptoms, diagnosis may not be clear until school age.
Two main features characterize autism spectrum disorders:
Persistent deficits in social communication and interaction
Restricted, repetitive patterns of behavior, interests, and/or activities
Both of these features must be present at a young age (although they may not be recognized at the time) and must be severe enough to significantly impair the child's ability to function at home, school, or other situations. Manifestations must be more pronounced than expected for the child’s developmental level and adjusted for norms in different cultures.
According to APO Research, The global Autism Spectrum Disorder market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Autism Spectrum Disorder include Otsuka, AstraZeneca, Pfizer, Eli Lilly and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autism Spectrum Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Spectrum Disorder.
The Autism Spectrum Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autism Spectrum Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Autism Spectrum Disorder Segment by Company
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson
Autism Spectrum Disorder Segment by Type
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Autism Spectrum Disorder Segment by Application
Children and Teenagers
Adults
Autism Spectrum Disorder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Autism Spectrum Disorder companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child’s behavior and development to make a diagnosis. Our report studies the market from 2014-2025, examining programs and medications used to the patient with autism.
Symptoms and Signs
Autism spectrum disorders may manifest during the first year of life but, depending on severity of symptoms, diagnosis may not be clear until school age.
Two main features characterize autism spectrum disorders:
Persistent deficits in social communication and interaction
Restricted, repetitive patterns of behavior, interests, and/or activities
Both of these features must be present at a young age (although they may not be recognized at the time) and must be severe enough to significantly impair the child's ability to function at home, school, or other situations. Manifestations must be more pronounced than expected for the child’s developmental level and adjusted for norms in different cultures.
According to APO Research, The global Autism Spectrum Disorder market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Autism Spectrum Disorder is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Autism Spectrum Disorder include Otsuka, AstraZeneca, Pfizer, Eli Lilly and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Autism Spectrum Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autism Spectrum Disorder.
The Autism Spectrum Disorder market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autism Spectrum Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Autism Spectrum Disorder Segment by Company
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson
Autism Spectrum Disorder Segment by Type
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others
Autism Spectrum Disorder Segment by Application
Children and Teenagers
Adults
Autism Spectrum Disorder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autism Spectrum Disorder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autism Spectrum Disorder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autism Spectrum Disorder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Autism Spectrum Disorder companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
87 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Autism Spectrum Disorder Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global Autism Spectrum Disorder Market Size by Region (2020-2031)
- 1.4.1 Global Autism Spectrum Disorder Market Size by Region (2020-2025)
- 1.4.2 Global Autism Spectrum Disorder Market Size by Region (2026-2031)
- 1.5 Key Regions Autism Spectrum Disorder Market Size (2020-2031)
- 1.5.1 North America Autism Spectrum Disorder Market Size Growth Rate (2020-2031)
- 1.5.2 Europe Autism Spectrum Disorder Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific Autism Spectrum Disorder Market Size Growth Rate (2020-2031)
- 1.5.4 South America Autism Spectrum Disorder Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa Autism Spectrum Disorder Market Size Growth Rate (2020-2031)
- 2 Autism Spectrum Disorder Market by Type
- 2.1 Type Introduction
- 2.1.1 Autistic Disorder
- 2.1.2 Asperger Syndrome
- 2.1.3 Childhood Disintegrative Disorder
- 2.1.4 Others
- 2.2 Global Autism Spectrum Disorder Market Size by Type
- 2.2.1 Global Autism Spectrum Disorder Market Size Overview by Type (2020-2031)
- 2.2.2 Global Autism Spectrum Disorder Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global Autism Spectrum Disorder Market Size Forecasted by Type (2026-2031)
- 2.3 Global Autism Spectrum Disorder Market Size by Regions
- 2.3.1 North America Autism Spectrum Disorder Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe Autism Spectrum Disorder Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific Autism Spectrum Disorder Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America Autism Spectrum Disorder Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa Autism Spectrum Disorder Market Size Breakdown by Type (2020-2025)
- 3 Autism Spectrum Disorder Market by Application
- 3.1 Type Introduction
- 3.1.1 Children and Teenagers
- 3.1.2 Adults
- 3.2 Global Autism Spectrum Disorder Market Size by Application
- 3.2.1 Global Autism Spectrum Disorder Market Size Overview by Application (2020-2031)
- 3.2.2 Global Autism Spectrum Disorder Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global Autism Spectrum Disorder Market Size Forecasted by Application (2026-2031)
- 3.3 Global Autism Spectrum Disorder Market Size by Regions
- 3.3.1 North America Autism Spectrum Disorder Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe Autism Spectrum Disorder Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific Autism Spectrum Disorder Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America Autism Spectrum Disorder Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa Autism Spectrum Disorder Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 Autism Spectrum Disorder Industry Trends
- 4.2 Autism Spectrum Disorder Industry Drivers
- 4.3 Autism Spectrum Disorder Industry Opportunities and Challenges
- 4.4 Autism Spectrum Disorder Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by Autism Spectrum Disorder Revenue (2020-2025)
- 5.2 Global Autism Spectrum Disorder Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global Autism Spectrum Disorder Key Company Headquarters & Area Served
- 5.4 Global Autism Spectrum Disorder Company, Product Type & Application
- 5.5 Global Autism Spectrum Disorder Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Autism Spectrum Disorder Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Autism Spectrum Disorder Players Market Share by Revenue in 2024
- 5.6.3 2024 Autism Spectrum Disorder Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 Otsuka
- 6.1.1 Otsuka Comapny Information
- 6.1.2 Otsuka Business Overview
- 6.1.3 Otsuka Autism Spectrum Disorder Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 Otsuka Autism Spectrum Disorder Product Portfolio
- 6.1.5 Otsuka Recent Developments
- 6.2 AstraZeneca
- 6.2.1 AstraZeneca Comapny Information
- 6.2.2 AstraZeneca Business Overview
- 6.2.3 AstraZeneca Autism Spectrum Disorder Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 AstraZeneca Autism Spectrum Disorder Product Portfolio
- 6.2.5 AstraZeneca Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Comapny Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Autism Spectrum Disorder Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Pfizer Autism Spectrum Disorder Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 Eli Lilly
- 6.4.1 Eli Lilly Comapny Information
- 6.4.2 Eli Lilly Business Overview
- 6.4.3 Eli Lilly Autism Spectrum Disorder Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 Eli Lilly Autism Spectrum Disorder Product Portfolio
- 6.4.5 Eli Lilly Recent Developments
- 6.5 Johnson & Johnson
- 6.5.1 Johnson & Johnson Comapny Information
- 6.5.2 Johnson & Johnson Business Overview
- 6.5.3 Johnson & Johnson Autism Spectrum Disorder Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 Johnson & Johnson Autism Spectrum Disorder Product Portfolio
- 6.5.5 Johnson & Johnson Recent Developments
- 7 North America
- 7.1 North America Autism Spectrum Disorder Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America Autism Spectrum Disorder Market Size by Country (2020-2025)
- 7.3 North America Autism Spectrum Disorder Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe Autism Spectrum Disorder Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe Autism Spectrum Disorder Market Size by Country (2020-2025)
- 8.3 Europe Autism Spectrum Disorder Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Autism Spectrum Disorder Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific Autism Spectrum Disorder Market Size by Country (2020-2025)
- 9.3 Asia-Pacific Autism Spectrum Disorder Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America Autism Spectrum Disorder Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America Autism Spectrum Disorder Market Size by Country (2020-2025)
- 10.3 South America Autism Spectrum Disorder Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Autism Spectrum Disorder Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa Autism Spectrum Disorder Market Size by Country (2020-2025)
- 11.3 Middle East & Africa Autism Spectrum Disorder Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
